| Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA) A Mestrón, SM Webb, R Astorga, P Benito, M Catalá, S Gaztambide, ... European Journal of Endocrinology 151 (4), 439-446, 2004 | 537 | 2004 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, ... European Journal of Endocrinology 165 (4), 509-515, 2011 | 177 | 2011 |
| Oxford textbook of endocrinology and diabetes JAH Wass, PM Stewart Oxford University Press, USA, 2011 | 148 | 2011 |
| Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: Tubular reabsorption of phosphate and 1, 25 (OH) 2 D serum levels are associated with PHEX … M Morey, L Castro-Feijóo, J Barreiro, P Cabanas, M Pombo, M Gil, ... BMC medical genetics 12, 1-11, 2011 | 102 | 2011 |
| Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone AJ van der Lely, I Bernabeu, J Cap, P Caron, A Colao, J Marek, ... European journal of endocrinology 164 (3), 325-333, 2011 | 92 | 2011 |
| Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA) G Sesmilo, S Gaztambide, E Venegas, A Picó, C Del Pozo, C Blanco, ... Pituitary 16, 115-121, 2013 | 88 | 2013 |
| Pegvisomant and cabergoline combination therapy in acromegaly I Bernabeu, C Alvarez-Escolá, AE Paniagua, T Lucas, I Pavón, ... Pituitary 16, 101-108, 2013 | 72 | 2013 |
| Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues J Oriola, T Lucas, I Halperin, M Mora, MJ Perales, C Alvarez-Escolá, ... European Journal of Endocrinology 168 (1), 9-13, 2013 | 69 | 2013 |
| Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis E Fernandez-Rodriguez, C Quinteiro, J Barreiro, M Marazuela, I Pereiro, ... Neuroendocrinology 93 (3), 181-188, 2011 | 67 | 2011 |
| Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study M Marazuela, AE Paniagua, MD Gahete, T Lucas, C Alvarez-Escolá, ... The Journal of Clinical Endocrinology & Metabolism 96 (2), E251-E259, 2011 | 67 | 2011 |
| The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly I Bernabeu, C Alvarez-Escola, C Quinteiro, T Lucas, M Puig-Domingo, ... The Journal of Clinical Endocrinology & Metabolism 95 (1), 222-229, 2010 | 65 | 2010 |
| Pegvisomant-Induced Liver Injury Is Related to the UGT1A1*28 Polymorphism of Gilbert’s Syndrome I Bernabeu, M Marazuela, T Lucas, L Loidi, C Alvarez-Escola, ... The Journal of Clinical Endocrinology & Metabolism 95 (5), 2147-2154, 2010 | 63 | 2010 |
| Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous … M Marazuela, T Lucas, C Alvarez-Escolá, M Puig-Domingo, ... European Journal of Endocrinology 160 (4), 535-542, 2009 | 61 | 2009 |
| Hypopituitarism after traumatic brain injury E Fernandez-Rodriguez, I Bernabeu, AI Castro, FF Casanueva Endocrinology and Metabolism Clinics 44 (1), 151-159, 2015 | 53 | 2015 |
| Molecular profiling for acromegaly treatment: a validation study M Puig-Domingo, J Gil, M Sampedro-Nuñez, M Jordà, SM Webb, G Serra, ... Endocrine-Related Cancer 27 (6), 375-389, 2020 | 51 | 2020 |
| Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer AR Garcia-Rendueles, JS Rodrigues, MER Garcia-Rendueles, ... Oncogene 36 (5), 652-666, 2017 | 51 | 2017 |
| Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients E Fernandez‐Rodriguez, M Lopez‐Raton, P Andujar, IM Martinez‐Silva, ... Clinical Endocrinology 78 (2), 278-284, 2013 | 49 | 2013 |
| Hypopituitarism following traumatic brain injury: determining factors for diagnosis FF CASANUEVA, AI Castro, E Fernandez-Rodriguez, I Bernabeu, ... Frontiers in endocrinology 2, 9115, 2011 | 45 | 2011 |
| Cabergoline treatment in acromegaly: pros M Marazuela, A Ramos-Leví, M Sampedro-Núnez, I Bernabeu Endocrine 46, 215-219, 2014 | 37 | 2014 |
| Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment? I Bernabeu, FF Casanueva Endocrine 44, 273-274, 2013 | 32 | 2013 |
Antonio Picoprofesor de medicinaVerified email at umh.es
